Hybrid Solutions
OnAsset offers enhanced, custom supply chain monitoring solutions to meet the specific challenges you face.
Chugai unveils results from study for NMOSD drug satralizumab
Chugai has announced results from the Phase III study for NMOSD drug satralizumab. Credit: Michal Jarmoluk from Pixabay.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
OnAsset Intelligence
OnAsset’s SENTRY devices are widely used for real-time tracking and...
About
OnAsset’s SENTRY devices are widely used for real-time tracking and monitoring life sciences and pharmaceutical shipments around the globe.
FollowMake an Enquiry
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry
-
Emisphere Technologies
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced...
About
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced oral formulations for pharmaceutical developers.
FollowMake an Enquiry
